KRMD

Koru Medical Systems Stock Analysis

AI Rating

Fair
  • Quality2/10
  • Growth 7/10
  • Value 1/10
Koru Medical Systems sales and earnings growth
KRMD Growth
Good
  • Revenue Y/Y 22.23%
  • EPS Y/Y 53.85%
  • FCF Y/Y 71.19%
Koru Medical Systems gross and profit margin trends
KRMD Profitability
Neutral
  • Gross margin 62.30%
  • EPS margin -6.40%
  • ROIC 5Y -37.54%
Koru Medical Systems net debt vs free cash flow
KRMD Risk
Great
  • Debt / Equity 0.2
  • Debt / FCF 0.0
  • Interest coverage 999.0

Koru Medical Systems stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗